KLRA compared with HTFL: revenue, margins and what each company keeps, and the suppliers and customers both name

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

HTFLHeartflow, Inc.

Mkt capRevenueRevenue

Compare

KLRAKailera Therapeutics, Inc.

HTFLHeartflow, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KLRA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.34%—

HTFL

2 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.4%▲+35.70%×3.43

May 15 '26±11.5%▼−12.17%×1.06

= impliedKLRA realized, solidHTFL realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

Q1 FY26

±17.1%

▲+1.65%

×0.09

Nov 13 '25—▼−13.43%—

KLRAKailera Therapeutics, Inc.

12.18▼−5.33%· post 12.33

Mkt cap$1.3BRevenue—

HTFLHeartflow, Inc.

54.50▼−7.70%· post 54.64

ClosedNov 2 '26

Mkt cap$4.7BRevenue$64MQ2 FY26

Compare

ClosedNov 2 '26

KLRAKailera Therapeutics, Inc.

HTFLHeartflow, Inc.

12.18▼−5.33%post 12.33

Price

54.50▼−7.70%post 54.64

$1.3B

Mkt cap

$4.7B

—

Revenue

$64MQ2 FY26

KLRA12.18▼−5.33%vsHTFL54.50▼−7.70%ClosedNov 2 '26